New Targeted Melanoma Drug Approved.

New Targeted Melanoma Drug Approved.

The FDA approved a vemurafenib (ZELBORAF®), for the treatment of advanced melanoma.  The drug can only be used to treat patients whose cancers have mutations in the BRAF gene.  For those patients, vemurafenib has been shown be more effective than existing treatments.  The drug is given as a pill.